Regeneron (REGN), Sanofi (SNY) Announce Positive Top-Line Phase 3 ODYSSEY Data
Tweet Send to a Friend
Regeneron (NASDAQ: REGN) and Sanofi (NYSE: SNY) announced that nine new Phase 3 ODYSSEY trials of alirocumab in people with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE